Frontiers Current Pharmacological Strategies for Duchenne

Hypochlorous acid exposure impairs skeletal muscle function and Ca2+ signalling: implications for Duchenne muscular dystrophy pathology - Lea - 2023 - The Journal of Physiology - Wiley Online Library

Frontiers Elucidation of bioinformatic-guided high-prospect drug repositioning candidates for DMD via Swanson linking of target-focused latent knowledge from text-mined categorical metadata

Frontiers Treating Duchenne Muscular Dystrophy: The Promise of Stem Cells, Artificial Intelligence, and Multi-Omics

Therapeutic approaches for Duchenne muscular dystrophy

Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future

Frontiers Advance in Drug Delivery for Ageing Skeletal Muscle

hiPSCs To Study And Identify Novel Drug Targets In Duchenne Muscular Dystrophy

Frontiers Drug development progress in duchenne muscular dystrophy

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing

PDF) Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Genes, Free Full-Text

Recent Therapeutic Advances in Duchenne Muscular Dystrophy (DMD) Models - Aurora Scientific

Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challenges - The Lancet Respiratory Medicine